People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

93.00CHF
27 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
CHF93.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,339,712
52-wk High
CHF93.00
52-wk Low
CHF67.45

Search Stocks

Vanhaecke, Erwin 

Brief Biography

Mr. Erwin Vanhaecke, Ph.D., serves as Head Novartis Group Quality at Novartis AG since January 2013. Mr. Vanhaecke previously served as Senior Vice President, Global Quality Operations at Alcon. He joined Alcon in 1990 as Quality Assurance Manager of the manufacturing facility in Belgium. Since then, his other roles have included Quality Assurance/Regulatory Affairs Manager, Northern Europe; Group Director, Quality Assurance; Vice President, Corporate Quality Assurance – Pharmaceutical; Vice President, Corporate Quality Assurance – Surgical Products; and Vice President, Global Quality Assurance and Compliance. Prior to joining Alcon, Mr. Vanhaecke served as a researcher and lecturer in pharmaceutical microbiology at the State University of Ghent in Belgium, where he earned a degree in pharmacy and a Ph.D. in pharmaceutical sciences. He also received a post-graduate degree in management from the VLEKHO School in Brussels, Belgium.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,366,320

Joseph Jimenez

13,228,200

Ulrich Lehner

853,107

Harry Kirsch

--

Peter Kornicker

--

Felix Ehrat

3,584,790
As Of 30 Dec 2012
Search Stocks